FDA approves manufacturing supplement for Gland's epinephrine ANDASep 25Weekly roundup, 3 itemsatomoxetineatovaquone
Apnimed posts Phase 3 SynAIRgy results for AD109 in obstructive sleep apneaSep 11Trial updateAD109Apnimed
Apnimed's OSA drug NDA accepted by FDA, PDUFA date set for February 2027Sep 8Quarterly updateAD109Apnimed
Apnimed posts Phase 2 MARIPOSA results showing AD109 cut AHI4 versus placeboAug 12Trial updateAD109AD504
Lilly posts ACHIEVE-J results; Olumiant, Strattera labels updatedJul 2Weekly roundup, 5 itemsabemaciclibbaricitinib